Home Ingredients enfinity® Paraxanthine
CognitiveEnergy

enfinity® Paraxanthine

Evidence Level
Moderate
3 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

enfinity® is a branded, pharmaceutical-grade form of paraxanthine, the primary metabolite of caffeine in the human body. After ingesting caffeine, roughly 80% is metabolized to paraxanthine by hepatic CYP1A2, and a growing body of branded research suggests that supplementing paraxanthine directly delivers many of caffeine's cognitive and performance benefits with a different side-effect profile, including potentially less reported jitter, less impact on heart rate, and a shorter half-life. Acute and short-term dose-response trials at 50-200 mg in healthy adults have explored effects on attention, memory, reaction time, and exercise-related cognition, while preclinical and safety toxicology studies support a no-observed-adverse-effect level well above typical human serving sizes. As a newer category, enfinity® is most often used at 100-200 mg in cognitive and pre-workout formulas.

Studied Dose 100-200 mg per serving; 50, 100, and 200 mg evaluated in published dose-response trials.
Active Compound Paraxanthine (1,7-dimethylxanthine), the primary methylxanthine metabolite of caffeine, supplied as 95%+ pure pharmaceutical-grade powder.

Benefits

Supports Cognitive Performance

Acute trials of 100-200 mg paraxanthine have reported improvements in reaction time, attention, and short-term memory in healthy adults compared with placebo, supporting use as a focus and mental-energy ingredient.

Supported by Trial 2, Trial 1

Helps Sustain Attention Under Load

Single-dose work suggests paraxanthine may help support sustained attention on demanding tasks, with effects in the range typically associated with moderate caffeine doses.

Supported by Trial 2, Trial 1

May Support Post-Exercise Cognition

In trained runners, paraxanthine has been compared with caffeine after a 10-km run, with the paraxanthine condition showing favorable effects on prefrontal cortex function and reaction time relative to caffeine and placebo.

Supported by Trial 3, Trial 2

Caffeine Metabolite With a Distinct Profile

As the primary metabolite of caffeine, paraxanthine shares the adenosine-antagonism mechanism that drives focus and arousal, while a shorter half-life and different receptor binding profile may translate to a smoother subjective experience in some users.

Supported by Trial 3

Mechanism of action

1

Adenosine Receptor Antagonism

Paraxanthine competitively blocks adenosine A1 and A2A receptors in the central nervous system, reducing the sleep-promoting and fatigue-signaling effects of adenosine and supporting wakefulness and focus.

2

Dopamine and Catecholamine Signaling

Through A2A receptor blockade, paraxanthine indirectly enhances dopaminergic signaling in regions associated with motivation, attention, and reward — a mechanism shared with caffeine.

3

Lipolysis and Bioenergetic Effects

Like other methylxanthines, paraxanthine increases cAMP and supports lipolysis at higher doses, with potential downstream effects on substrate availability during exercise.

Clinical trials

1
Dose-Response of Paraxanthine on Cognition

Double-blind, placebo-controlled, crossover trial; 50, 100, and 200 mg paraxanthine vs placebo with 7-day daily intake assessments

12 healthy young adults

Acute paraxanthine ingestion was associated with improvements across several cognitive measures, most consistently at the 100-200 mg doses; 7-day daily ingestion was reported to be free of clinically significant side effects.

2
Acute 200 mg Paraxanthine and Cognition

Double-blind, placebo-controlled, crossover trial; single 200 mg paraxanthine vs placebo on cognitive and attentional tasks

13 healthy male and female participants

A single 200 mg dose was associated with improvements in markers of cognitive function and short-term memory and helped sustain attention compared with placebo, with no reported adverse events.

3
Paraxanthine vs Caffeine After Endurance Running

Double-blind, randomized, crossover trial; 200 mg paraxanthine vs 200 mg caffeine vs placebo combinations following a 10-km run

12 trained runners

Paraxanthine was associated with greater improvements in cognitive function after the 10-km run than caffeine; co-ingesting both did not produce additive benefits, suggesting distinct nootropic action.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated in trials at 50-200 mg; mild headache or jitteriness possible at higher doses.
May cause GI upset, especially on an empty stomach.
Stimulant cross-tolerance and sleep disruption are possible if taken late in the day.
Long-term human safety data beyond short trial durations remain limited.

Important Drug interactions

Theoretical additive effects with caffeine and other stimulants — combine cautiously.
CYP1A2 inhibitors and inducers may modify paraxanthine pharmacokinetics.
Discuss use with a clinician if you take antiarrhythmics or stimulant medications.

More Cognitive Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…

Explore Other Ingredients

Cognitive
Citicoline
Citicoline (CDP-choline) is a naturally-occurring intermediate in phosphatidylcholine bios…
Cognitive
Alpha-GPC
Alpha-GPC (L-alpha-glycerylphosphorylcholine) is a natural compound and dietary supplement…
Cognitive
PQQ (Pyrroloquinoline Quinone)
Pyrroloquinoline quinone (PQQ) is a redox-active coenzyme and potent antioxidant naturally…

Frequently asked questions about enfinity® Paraxanthine

What is the recommended dosage of enfinity® Paraxanthine?

The clinically studied dose for enfinity® Paraxanthine is 100-200 mg per serving; 50, 100, and 200 mg evaluated in published dose-response trials.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is enfinity® Paraxanthine used for?

enfinity® Paraxanthine is studied for supports cognitive performance, helps sustain attention under load, may support post-exercise cognition. Acute trials of 100-200 mg paraxanthine have reported improvements in reaction time, attention, and short-term memory in healthy adults compared with placebo, supporting use as a focus and mental-energy ingredient.

Are there side effects from taking enfinity® Paraxanthine?

Reported potential side effects may include: Generally well tolerated in trials at 50-200 mg; mild headache or jitteriness possible at higher doses. May cause GI upset, especially on an empty stomach. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does enfinity® Paraxanthine interact with medications?

Known drug interactions may include: Theoretical additive effects with caffeine and other stimulants — combine cautiously. CYP1A2 inhibitors and inducers may modify paraxanthine pharmacokinetics. Consult a pharmacist or healthcare provider if you take prescription medications.

Is enfinity® Paraxanthine good for cognitive?

Yes, enfinity® Paraxanthine is researched for Cognitive support. Acute trials of 100-200 mg paraxanthine have reported improvements in reaction time, attention, and short-term memory in healthy adults compared with placebo, supporting use as a focus and mental-energy ingredient.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Xing D, Yoo C, Gonzalez D, et al. Dose-response of paraxanthine on cognitive function: a double blind, placebo controlled, crossover trial. Nutrients. 2021;13(12):4478. doi: 10.3390/nu13124478.PubMedUsed to support: Crossover trial of 50/100/200 mg paraxanthine reporting cognitive improvements (most consistent at 100-200 mg) and tolerability over 7-day daily intake.
  2. Yoo C, Xing D, Gonzalez D, et al. Acute paraxanthine ingestion improves cognition and short-term memory and helps sustain attention in a double-blind, placebo-controlled, crossover trial. Nutrients. 2021;13(11):3980. doi: 10.3390/nu13113980.PubMedUsed to support: Crossover trial of single 200 mg paraxanthine in 13 adults showing improved cognitive function, short-term memory, and sustained attention vs placebo.
  3. Purpura M, Jäger R, Falk M. An assessment of mutagenicity, genotoxicity, acute-, subacute and subchronic oral toxicity of paraxanthine (1,7-dimethylxanthine). Food Chem Toxicol. 2021;158:112579. doi: 10.1016/j.fct.2021.112579.PubMedUsed to support: Comprehensive toxicology battery establishing NOAEL ≥300 mg/kg/day in 90-day subchronic rat study, no genotoxicity or mutagenicity signal.